LivaNova PLC ( LIVN) - Key Metrics
LIVN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $7.10 | $1.97 | $1.21 | $0.64 |
| 2026Q1 | $6.62 | $0.41 | $0.28 | $0.02 |
| 2025Q4 | $6.62 | $0.57 | $1.51 | $0.92 |
| 2025Q3 | $6.55 | $0.49 | $1.56 | $1.14 |
| 2025Q2 | $6.46 | $0.50 | $1.15 | $0.88 |
LIVN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 10.38 |
| 2026Q1 | 0% | 38.76 |
| 2025Q4 | 0% | 26.99 |
| 2025Q3 | 0% | 26.72 |
| 2025Q2 | 0% | 22.51 |
LIVN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.77% | 0% |
| 2026Q1 | 0.03% | 0% |
| 2025Q4 | 1.50% | 0% |
| 2025Q3 | 2.17% | 0% |
| 2025Q2 | 1.94% | 0% |
LIVN
Price: $76.55
52 week price:
Payout Ratio Range:
Earnings Per Share: 3.39 USD
P/E Ratio: 22.56
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United Kingdom
Volume: 315000
Ebitda: 55.0 millionMarket Capitalization: 4.1 billion